Loading…
Synthesis of new acridines and hydrazones derived from cyclic β-diketone for cytotoxic and antiviral evaluation
Cyclic β-diketone namely, dimedone was utilized to prepare different chemical entities whether cyclic such as acridines, thiadiazole and triazole or acyclic systems as hydrazide, hydrazones, thiosemicarbazide and semicarbazide. The structures of the novel compounds were determined using elemental an...
Saved in:
Published in: | European journal of medicinal chemistry 2009-09, Vol.44 (9), p.3680-3686 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cyclic β-diketone namely, dimedone was utilized to prepare different chemical entities whether cyclic such as acridines, thiadiazole and triazole or acyclic systems as hydrazide, hydrazones, thiosemicarbazide and semicarbazide. The structures of the novel compounds were determined using elemental ana-lyses and various spectroscopic methods. Most acyclic derivatives especially semicarbazide
19, hydrazide
9 and thiosemicarbazide
16 showed a higher
in vitro cytotoxic activity against hepatoma cell line (HepG2) than the cyclized acridine derivatives. The antiviral activity of the new compounds against
Hepatitis A Virus (HAV) using the plague infectivity reduction assay revealed that the acridine
4 and the hydrazone
12 were more active than the reference drug amantadine.
From cyclic β-diketone(dimedone,
1), nonclassical acridines, hydrazones and semicarbazide were synthesized. The semicarbazide
19 showed the highest
in vitro cytotoxic activity against hepatoma cell line (HepG2). The antiviral study revealed that the acridine
4 and the hydrazone
12 were more active against
Hepatitis A Virus than the reference drug amantadine upon using the plague infectivity reduction assay.
[Display omitted] |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2009.04.001 |